SCHEMBL16258698

SCHEMBL16258698

CCC/C=C\C=N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14557216 1.00
SCHEMBL28792351 0.88
SCHEMBL11586274 0.82
SCHEMBL30266643 0.80
SCHEMBL731193 0.79 ALDH1A1 (0.43)
SCHEMBL731194 0.79 ALDH1A1 (0.43)
SCHEMBL3416292 0.78 TSHR (0.52)
SCHEMBL28756777 0.73 TSHR (0.37)
SCHEMBL681860 0.73
SCHEMBL13680090 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017192385-A1 HETEROARYL-1,2,4-TRIAZOLE AND HETEROARYL-TETRAZOLE COMPOUNDS FOR CONTROLLING ECTOPARASITES ELANCO TIERGESUNDHEIT AG (CH) 2017-11-09 WO disclosed
US-20160169998-A1 METHOD FOR CREATING HYPERPOLARIZATION AT MICROTESLA MAGNETIC FIELDS NATIONAL SCIENCE FOUNDATION 2016-06-16 US disclosed
EP-1670460-B1 PYRAZOLE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS BRISTOL MYERS SQUIBB CO (US) 2014-11-26 EP disclosed